| 0 | 💬 0 |
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-05-02 | #clinical trial #addiction #pharmacotherapy #obesity #comorbidity |